Quốc gia: New Zealand
Ngôn ngữ: Tiếng Anh
Nguồn: Medsafe (Medicines Safety Authority)
Budesonide 160ug; ; ; ; Formoterol fumarate 4.5ug;
AstraZeneca Limited
Budesonide 160 µg
200/6
Aerosol inhaler, metered dose
Active: Budesonide 160ug Formoterol fumarate 4.5ug Excipient: Apaflurane Macrogol 1000 Povidone
Inhaler, metered, 120 dose units
Prescription
Prescription
Aspen Oss B.V
Symbicort Rapihaler 100/6 is indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta2-agonist) is appropriate. This includes: · Patients who are not adequately controlled with inhaled corticosteroid therapy and ?as needed? inhaled short-acting beta-2 adrenoceptor agonists. · Patients who are already adequately controlled on regular separate long acting beta-agonist and inhaled corticosteroid therapies.
Package - Contents - Shelf Life: Inhaler, metered, - 120 dose units - 24 months from date of manufacture stored at or below 30°C 3 months opened stored at or below 30°C
1970-01-01
Vannair CMI 040222 Copyright 1(5) VANNAIR ® 100/6 AND VANNAIR ® 200/6 BUDESONIDE/FORMOTEROL, 100/6 OR 200/6 MICROGRAMS PER DOSE. CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some of the common questions people ask about VANNAIR. It does not contain all the information that is known about VANNAIR. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor will have weighed the risks of you taking VANNAIR against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT VANNAIR IS USED FOR VANNAIR is used to treat the inflammation caused by asthma. It also widens the airways so that you find it easier to breathe. To get the best effect, you should use VANNAIR as prescribed by your doctor, even when you have no symptoms. VANNAIR is also used to treat Chronic Obstructive Pulmonary Disease (COPD). COPD (which includes chronic bronchitis and emphysema) is a long term lung disease. There is often permanent narrowing and persistent inflammation of the airways. Symptoms may include difficulty in breathing (breathlessness or wheezing), coughing and increased sputum. VANNAIR when used as prescribed will help to control your COPD symptoms (i.e. breathing difficulties). VANNAIR contains the medicines budesonide and formoterol, which have different ways of treating your condition. Budesonide acts directly on your airways to reduce and prevent this inflammation. Formoterol works by opening your airways, making it easier for you to breathe. This effect starts within 1-3 minutes after inhaling the medicine and lasts for up to 12 hours. When you breathe in through the mouthpiece of the inhaler, your breath carries the medicine to your lungs. See the VANNAIR instructions in the pack. Asthma: Using VANNAIR regularly will help prevent asthma attacks and make it easier to breathe normally. It is not u Đọc toàn bộ tài liệu
V ANNAIR Data Sheet 161221 Copyright NEW ZEALAND DATA SHEET 1. PRODUCT NAME V ANNAIR ® 100/6, metered aerosol inhaler V ANNAIR ® , 200/6, metered aerosol inhaler 2. QUALITATIVE AND QUANTITATIVE COMPOSITION V ANNAIR is a pressurised metered dose inhaler (pMDI) in the following strengths: V ANNAIR ® 100/6: Each delivered dose (the dose that leaves the mouthpiece) contains as active constituents: budesonide 80 micrograms / inhalation and formoterol fumarate dihydrate 4.5 micrograms/inhalation. V ANNAIR ® 200/6: Each delivered dose (the dose that leaves the mouthpiece) contains as active constituents: budesonide 160 micrograms / inhalation and formoterol fumarate dihydrate 4.5 micrograms/inhalation. To avoid confusion, V ANNAIR is labelled as metered dose like S YMBICORT T URBUHALER ® . The following table gives the corresponding dose delivered to the patient. TABLE 1 V ANNAIR METERED DOSE (ΜG) CORRESPONDING DOSE DELIVERED TO PATIENT (ΜG)* BUDESONIDE FORMOTEROL BUDESONIDE FORMOTEROL 100/6 100 6 80 4.5 200/6 200 6 160 4.5 _* doses referred to in Symbicort publications_ Formoterol fumarate dihydrate is hereafter referred to as formoterol. For the full list of excipients see section 6.1. 3. PHARMACEUTICAL FORM Metered aerosol inhaler 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS ASTHMA V ANNAIR 100/6 AND 200/6 are indicated in the regular treatment of asthma where use of a combination (inhaled corticosteroid and long-acting beta-2-agonist) is appropriate. This includes: V ANNAIR Data Sheet 040222 2 Patients who are not adequately controlled with inhaled corticosteroid therapy and “as needed” inhaled short-acting beta-2 adrenoceptor agonists. Patients who are already adequately controlled on regular separate long acting beta- agonist and inhaled corticosteroid therapies. CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) V ANNAIR 200/6 is indicated for the symptomatic treatment of moderate to severe COPD (pre- bronchodilator FEV 1 ≤50% predicted normal) in adults with frequent symptoms despit Đọc toàn bộ tài liệu